{"id":"NCT03201965","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis","officialTitle":"A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-05","primaryCompletion":"2020-02-14","completion":"2024-11-19","firstPosted":"2017-06-28","resultsPosted":"2021-03-04","lastUpdate":"2025-05-25"},"enrollment":416,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Amyloidosis"],"interventions":[{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"Bortezomib","otherNames":[]},{"type":"DRUG","name":"Dexamethasone, 40 mg","otherNames":[]},{"type":"DRUG","name":"Daratumumab","otherNames":[]}],"arms":[{"label":"CyBorD alone (cyclophosphamide/bortezomib/dexamethasone)","type":"ACTIVE_COMPARATOR"},{"label":"CyBorD plus Daratumumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared with CyBorD alone in treatment of newly diagnosed amyloid light chain (AL) amyloidosis participants.","primaryOutcome":{"measure":"Percentage of Participants With Overall Complete Hematologic Response (CHR)","timeFrame":"Up to 2.4 years","effectByArm":[{"arm":"CyBorD","deltaMin":18.1,"sd":null},{"arm":"Daratumumab Plus CyBorD","deltaMin":53.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":140,"countries":["United States","Australia","Belgium","Brazil","Canada","China","Denmark","France","Germany","Greece","Hungary","Israel","Italy","Japan","Mexico","Netherlands","Poland","South Korea","Spain","Sweden","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36862168","36444227","34192431","32244252"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":28},"commonTop":["Oedema Peripheral","Diarrhoea","Constipation","Fatigue","Nausea"]}}